COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation

BMC Medical Genomics · Published 2026-08-05 · DOI 10.1186/s12920-026-02446-y

Free full text

Authors (4)

Shiyu Yang, Xia Lin, Wen Liu, Xiwei Hu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, S., Lin, X., Liu, W., et al. (2026). COL11A1 promotes Sorafenib resistance in lung adenocarcinoma: from bioinformatic discovery to functional validation. BMC Medical Genomics. https://doi.org/10.1186/s12920-026-02446-y

Related articles

• Discovery and validation of a prognostic SPP1/PLAU signature in HPV-negative oropharyngeal squamous cell carcinoma · BMC Medical Genomics · 2026 · Same journal
• Genetic evidence linking the promoter region and 5’-UTR deletion of GNAS with pseudohypoparathyroidism type 1 C · BMC Medical Genomics · 2026 · Same journal
• Development and pilot testing of a prostate cancer polygenic risk report · BMC Medical Genomics · 2026 · Same journal
• Integrated transcriptomic and metabolomic analysis identifies a core gene-metabolite network linking lysine degradation and propanoate metabolism to psoriasis pathogenesis · BMC Medical Genomics · 2026 · Same journal
• Identification of glutathione metabolism-related biomarkers in non-alcoholic fatty liver disease based on single-cell and bulk RNA sequencing · BMC Medical Genomics · 2026 · Same journal
• Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort · BMC Medical Genomics · 2026 · Same journal
• A novel pathogenic variant in folliculin identified in a Chinese family with BHD syndrome · BMC Medical Genomics · 2026 · Same journal
• CRABP2 upregulation in perichondral stem cells is associated with microtia · BMC Medical Genomics · 2026 · Same journal
• Genotypic and phenotypic spectrum of PRRT2-related variations: clinical analysis and treatment response in fourteen unrelated Chinese patients · BMC Medical Genomics · 2026 · Same journal
• Prevalence of Factor V Leiden mutation in yemeni women with gestational diabetes mellitus and recurrent pregnancy loss: a case-control study · BMC Medical Genomics · 2026 · Same journal